Tuesday 26 June 2018
A letter has been submitted to the Australian Commission on Safety and Quality in Health Care by each state’s Pelvic Mesh Support Groups and the Health Consumer organisations in each State and Territory across Australia, asking the Commission to comprehensively address the recommendations tabled in the Senate Report. You can download a copy of the letter below.
The Australian Commission on Safety and Quality in Health Care have released two consumer resources to assist and support to women who are considering treatment options in regard to Pelvic Organ Prolapse and Stress Urinary Incontinence. The resources were developed in consultation with many women across the country, who shared their lived experience at various meetings around the country. You can view both of the resources below.
The Australian Government is making changes to Medicare-funded urogynaecological services relating to pelvic organ prolapse repair, based on advice from the Medicare Benefits Schedule (MBS) Review Taskforce. You can view the factsheet below.
The Royal Australian College of General Practitioners (RACGP) has released a statement for General Practitioners outlining the impact of the senate enquiry on future treatment options. It outlines recommendations on how to treat women who have had mesh inserted and are exhibiting adverse symptoms, and information about treatment of women who experience pelvic organ prolapse and stress urinary incontinence. You can read the article here.
The Senate Report on The number of women in Australia who have had transvaginal mesh implants and related matters was released on 28 March 2018, and can be found here.
Australia’s state and territory based health consumer organisations have welcomed the recognition of the extent and impact of harm to women, and the recommendations contained in the Senate report. But they say they hoped the report had gone further. You can view their press release below.
A joint media release by Pelvic Mesh Support Groups across Australia is also available below.
Consumers Health Forum of Australia has also issued the media release below, in response to the Senate Report.
HCA is working with consumers, specialists and SA Health to develop a model of care for South Australian women, to support women who have been injured through the use of vaginal mesh.
You can find further information on the Australian Commission for Safety and Quality in Health Care website here.
On 28 November 2017, the Therapeutic Goods Administration (TGA) advised of the decision to remove transvaginal mesh products which have the sole use as the treatment of pelvic organ prolapse (POP) via transvaginal implantation from the Australian Register of Therapeutic Goods (ARTG).
The TGA website provides detail of this decision here.
The March HCASA Board meeting recently confirmed our capacity to continue our work well into 2020. HCASA is here to stay. We had expected to call a Special General Meeting at about this time to ask our members to consider the organisation’s future. After careful consideration of our financial position, our capacity and the importance of our work we are instead scheduling the launch of our new business prospectus. This is planned for Monday 17 June, Save the date.
You will have read in eNews that we have moved our offices upstairs from level 1 to 3 at 12 Pirie Street. Our team continues to do an amazing job building a viable and sustainable business future. You’ll hear more about this on/after 17 June. We would not have been able to consider such an optimistic future without the pragmatic and moral support of our members, partners and supporters. Thank you.
We encourage organisations and individuals who believe in our vision of ‘consumers at the centre of health’ to make sure they have current membership of HCASA. As you know, we are a state-wide, member-based incorporated association with no political affiliations. We provide the information, training and services people, services and policy makers need to ensure consumers have a powerful influence on the health services that they pay for, use and expect to support the health and wellbeing of all South Australians. This work must and will continue.
Debra Kay PSM
Board Chair HCASA
On behalf of the HCASA Board and Staff Team
There have been some changes at the Health and Community Service Complaints Commissioner (HCSCC). On 18 March 2019, South Australia implemented the Code of Conduct for Certain Health Care Workers which replaced the Code of Conduct for Unregistered Health Practitioners. This change aligns South Australia with the National Code of Conduct for Health Care Workers approved by the COAG Health Council. Unregistered health care workers who do not fall within the jurisdiction of the Australian Health Practitioner Regulation Agency (AHPRA) will have to comply with the code and display certain information where they practise.
The code establishes:
• A range of minimum standards for unregistered health care workers.
• Additional powers to the HCSCC if an unregistered health care worker is found to have breached the Code.
Law changes also came into effect that allow the Health and Community Services Complaints Commissioner to:
• Adopt prohibition orders imposed on individuals from across Australia.
• Investigate individual volunteers providing a health service.
• Restrict people who are subject to a prohibition order from advertising and promoting themselves as a health service.
• Issue a public statement to identify a person or warn the public when interim action has been taken.
You’ll also notice that the HCSCC has a new website, which the Health Consumer’s Alliance was consulted on. The new website is easier to navigate, provides clearer information and is consumer tested. Go check it out!
In 2019 HCA will work with consumers, partner agencies and other stakeholders to develop more focused training modules for consumers on topics such as:
One of the changes of not having a core funding base is that we will now be charging for our training, including consumer training. Fees will be kept as low as possible, and opportunities for subsidised training will be made available to consumers who do not have the capacity to pay.
Back to eNews here
Back to eNews here.
The Third Australian Atlas of Healthcare Variation, released 11 December 2018, investigates healthcare use in four clinical areas: paediatric and neonatal health, cardiac tests, thyroid investigations and treatments, and gastrointestinal investigations and treatments. It also examines national patterns in medicines use over time for four common groups of medicines: antipsychotics, opioids, antimicrobials and medications for attention deficit hyperactivity disorder (ADHD). A more detailed exploration of these data will be published in 2019.
Find out more here
Back to eNews here.
Thursday 30 May 2019
The 2019 annual Choosing Wisely National Meeting will bring together policy makers, consumers and other health care stakeholders for an interactive discussion on the opportunities, challenges, and highlights of the Choosing Wisely initiative as it continues to grow. Early bird registration is open until Thursday 18 April.
Find out more and register here.
Wednesday 30 January 2019
10am – 12pm
HCA is hosting a focus group for the South Australian Health and Community Services Complaints Commissioner (HCSCC). The focus group aims to gain consumer feedback on their current website to ensure it is user-friendly.
You can find out more and register here.
Back to eNews here.
Thursday 30 May 2019
The annual 2019 Choosing Wisely National Meeting will bring together policymakers, consumers and other health care stakeholders for an interactive discussion on the opportunities, challenges, and highlights of the choosing wisely initiative as it continues to grow. Early bird registration is open until Thursday 18 April. You can find out more about the meeting and the Choosing Wisely initiative here.